Cite
Zhao J, Li Z, Puri R, et al. Molecular profiling of individual FDA-approved clinical drugs identifies modulators of nonsense-mediated mRNA decay. Mol Ther Nucleic Acids. 2021;27:304-318doi: 10.1016/j.omtn.2021.12.003.
Zhao, J., Li, Z., Puri, R., Liu, K., Nunez, I., Chen, L., & Zheng, S. (2022). Molecular profiling of individual FDA-approved clinical drugs identifies modulators of nonsense-mediated mRNA decay. Molecular therapy. Nucleic acids, 27304-318. https://doi.org/10.1016/j.omtn.2021.12.003
Zhao, Jingrong, et al. "Molecular profiling of individual FDA-approved clinical drugs identifies modulators of nonsense-mediated mRNA decay." Molecular therapy. Nucleic acids vol. 27 (2022): 304-318. doi: https://doi.org/10.1016/j.omtn.2021.12.003
Zhao J, Li Z, Puri R, Liu K, Nunez I, Chen L, Zheng S. Molecular profiling of individual FDA-approved clinical drugs identifies modulators of nonsense-mediated mRNA decay. Mol Ther Nucleic Acids. 2021 Dec 10;27:304-318. doi: 10.1016/j.omtn.2021.12.003. eCollection 2022 Mar 08. PMID: 35024243; PMCID: PMC8718828.
Copy
Download .nbib